UroGen Pharma Ltd Sustainability Reports
UroGen Pharma Ltd. is a biotechnology company focused on developing and commercializing innovative non-surgical solutions for urothelial and specialty cancers. Its pipeline and approved products utilize its proprietary RTGel technology for sustained release delivery of medications.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300C0YCX7CG2G5D50
FIGI: BBG00GFCC622
9 reports from 2018 to 2025